RITES Q1 Results FY26: Q1 PAT Jumps 1.37% to ₹80.10 Crore; Revenue Surges 0.82% YoY

RITES Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

(Figures in crores)

RITES Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

RITES Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• RITES clocked Q1 FY26 consolidated revenue of ₹489.74 crores vs ₹485.76 crores. 
• On the profit front, RITES earned a consolidated PAT of ₹80.10 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹79.02 crore. 
• Consolidated PAT rose for the first quarter of FY26, was 1.37% YoY, and revenue rose 0.82% YoY. 
• As per the standalone figures, the quarterly PAT of RITES has increased by 2.76% and revenue has increased by 0.43% YoY.

RITES Share Price Performance

On the opening bell of 6th August 2025, the shares of RITES opened at ₹ per share. 258.95 However, the initial gains are wiped out as of now, and RITES shares are trading at ₹255.50 per share, lower than their opening price. 

Considering the long-term performance, RITES shares have yielded close to -26.70% returns in the past 1 year, and 5-year returns stand at 108.61%. Over the maximum timeframe, the RITES share provided 223.99% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in RITES shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : Navin Fluorine International Ltd Q1 Results FY26: Q1 PAT Rose 128.83% to ₹117.16 Crore; Revenue Surged 38.52% YoY

Recent Articles

Best Penny Stocks for Long Term in India | Penny Stocks in 2025

Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY

Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY

Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY

BLS International Services Q1 Results FY26: Q1 PAT Soars 49.76% to ₹171.00 Crore; Revenue Up 44.23% YoY